HF
CRDF icon

HRT Financial’s Cardiff Oncology CRDF Stock Holding History

HRT Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,408
Closed -$82K – 3929
2025
Q4 		$82K Buy
29,408
+15,073
+105% +$35K ﹤0.01% 2812
2025
Q3 		$29K Buy
+14,335
New +$39.6K ﹤0.01% 2661
2024
Q2 		– Sell
-67,889
Closed -$362K – 2348
2024
Q1 		$362K Buy
+67,889
New +$180K ﹤0.01% 1443
2021
Q2 		– Sell
-283,885
Closed -$2.63M – 2949
2021
Q1 		$2.63M Buy
+283,885
New +$3.45M 0.03% 482

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

HRT Financial's CRDF Position: Q1 2026 in Review

HRT Financial sold out of Cardiff Oncology (CRDF) in Q1 2026, closing a stake of 29,408 shares — an estimated $82K sold.

HRT Financial first reported a position in CRDF in Q1 2021 and held it in 4 quarters. The position peaked at $2.63M in Q1 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • HRT Financial reported no remaining Cardiff Oncology position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 29,408 Cardiff Oncology shares in Q1 2026, an estimated $82K.
  • HRT Financial first reported a position in Cardiff Oncology in Q1 2021 and held it in 4 quarters.
  • HRT Financial's Cardiff Oncology position peaked at $2.63M in Q1 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.